Insight2016-08-01T14:51:33-04:00

Laidlaw Venture Partners Adds Industry Leading CEOs Jeffrey O’Donnell and Dr. Ann Marie Sastry to its Board of Advisors

June 15th, 2020|Comments Off on Laidlaw Venture Partners Adds Industry Leading CEOs Jeffrey O’Donnell and Dr. Ann Marie Sastry to its Board of Advisors

Laidlaw Venture Partners, the venture capital arm of Laidlaw & Company (UK) Ltd., today announced the addition of Jeffrey O'Donnell and Dr. Ann Marie Sastry to its Board of Advisors. With more than 50 years of combined experience in leading companies across medical devices and artificial intelligence (AI) technology, O'Donnell and Sastry will help guide Laidlaw Venture Partners in building and expanding its already diverse portfolio of innovative companies.

Laidlaw served as Sole Book-Runner on the $5mm Follow-On Offering for Hoth Therapeutics (HOTH)

May 24th, 2020|Comments Off on Laidlaw served as Sole Book-Runner on the $5mm Follow-On Offering for Hoth Therapeutics (HOTH)

Laidlaw Capital Markets is pleased to announce yesterday's pricing of a $5,000,000 Follow-On Offering for Hoth Therapeutics (HOTH). Laidlaw proudly served as the Sole Book Runner on the transaction. See Press Release Read More...

Laidlaw served as Introducing Broker on the $10.8mm financing for Biosig Technologies (BSGM), through its subsidiary ViralClear.

May 20th, 2020|Comments Off on Laidlaw served as Introducing Broker on the $10.8mm financing for Biosig Technologies (BSGM), through its subsidiary ViralClear.

Laidlaw Venture Partners client Biosig Technologies (BSGM) through its newly formed subsidiary ViralClear, closes $10,800,000 financing. Laidlaw is proud to have acted as am Introducing Broker on this financing. See Press Release Read More...

912, 2020

Laidlaw served as Lead Manager on the $147,500,000 Offering for Curis Inc (CRIS)

By |December 9th, 2020|News|

Laidlaw Capital Markets is pleased to have served as a Lead Manager on a $147,500,000 Follow-On Offering for Curis Inc (CRIS). See press release

Ready to talk?

Lorem ipsum dolor sit amet, consectetur adipisicing elit mod tempor incididunt ut labore et dolore magna aliqua.

Site Info

Home
Contact Us
Company History

Legal

Terms and Conditions
Legal Information
Privacy Policy
Glossary
Record of Processing Activities
GDPR Rights Exercise Form

Disclosures

FINRA
SIPC
FCA
Business Continuity Plan Disclosure
Brokercheck
REGBI
StoneX Annual Disclosure
Options Disclosure Booklet

Contact Info

© 2024 Copyright Laidlaw & Company (UK) Ltd. – All Rights Reserved. Laidlaw & Company (UK) Ltd., a FINRA broker-dealer registered in the United States, clears on a fully-disclosed basis through StoneX, a member of the Securities Investor Protection Corporation (SIPC). Laidlaw & Company International Limited is authorized and regulated by the Financial Conduct Authority (FCA) in the UK (Firm Reference No: 537165).

© Copyright 2016 Laidlaw & Company (UK) Ltd. - All Rights Reserved. Laidlaw & Company (UK) Ltd., a FINRA broker-dealer registered in the United States, clears on a fully-disclosed basis through INTL FCStone Financial Inc., a member of the Securities Investor Protection Corporation (SIPC). Laidlaw & Company International Limited is authorized and regulated by the Financial Conduct Authority (FCA) in the UK (Firm Reference No: 537165).

You are now leaving Laidlaw & Company (UK) Ltd.

This link to the Private Stakes Program is provided as a service to Members, Clients and interested parties and will direct you to a third-party site independent of Laidlaw & Company (UK) Ltd.

Neither Laidlaw & Company (UK) Ltd. nor Laidlaw Private Equity, LLC own or manage the Private Stakes Program alternative investment vehicles. They are not responsible for the content of the site and do not guarantee the accuracy or completeness of any information or material contained therein.

Associated persons of Laidlaw & Company (UK) Ltd. and Laidlaw Private Equity, LLC are involved in the management and administration of each alternative investment vehicle described in the Private Stakes Program website.

Go to Top